Search | Page 17 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

    ... newly diagnosed acute myeloid leukemia. Drugs used in chemotherapy , such as clofarabine, daunorubicin hydrochloride, cytarabine, ... them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. It is not yet known which ...

    Clinical Trial last updated 04/28/2016 - 12:10pm.

  2. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... Traditionally, very strong cancer treatment drugs ( chemotherapy ) and radiation are used to prepare a subject's body for ... attack the recipient's normal body. Recently, less intense chemotherapy and radiation regimens have been employed (these are called ...

    Clinical Trial last updated 05/09/2016 - 3:36pm.

  3. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... Traditionally, very strong cancer treatment drugs ( chemotherapy ) and radiation are used to prepare a subject's body for ... attack the recipient's normal body. Recently, less intense chemotherapy and radiation regimens have been employed (these are called ...

    Clinical Trial last updated 04/27/2016 - 1:04pm.

  4. Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

    ... that can be given safely when it is combined with two chemotherapy drugs ( fludarabine and cytarabine). This study will be ... participant's best interest based on disease progression. Chemotherapy may be delayed by 1-3 days if clinically indicated. Other ...

    Clinical Trial last updated 04/28/2016 - 9:48am.

  5. TBI Dose De-escalation for Fanconi Anemia

    ... -6). 2) Day -5 through Day -2, subjects will receive a chemotherapy regimen of Fludarabine and Cyclophosphamide ... Day -5 through Day -2, subjects will receive chemotherapy of Cyclophosphamide via central line (i.e. Hickman or Broviac),10 ...

    Clinical Trial last updated 04/28/2016 - 9:06am.

  6. Nonmyeloablative Allogeneic Transplant (Mini-allo)

    ... Cell Lymphoma (any Stage - must have received induction chemotherapy ) Multiple Myeloma (10% residual plasmacytosis following anthracycline-based chemotherapy or residual disease following autologous transplant) ...

    Clinical Trial last updated 04/28/2016 - 2:13pm.

  7. MEDALIST Trial

    ... as the result of chemical injury or treatment with chemotherapy and/or radiation for other diseases. Known clinically ...

    Clinical Trial last updated 02/22/2017 - 11:42am.

  8. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... hematologic malignancies not curable by conventional chemotherapy . Responses to conventional treatment range from zero to 30% ... lymphoma, Hodgkin lymphoma and multiple myeloma with chemotherapy sensitive disease who are ineligible for an autologous transplant. ...

    Clinical Trial last updated 04/29/2016 - 10:06am.

  9. Risk of developing MDS and AML after radiation treatment for breast cancer

    ... increases in patients who receive multiple rounds of chemotherapy and radiation therapy, and also in those who undergo stem cell ... lymphoma. Read more about t-MDS Radiation and chemotherapy are key components of cancer treatments and carry an increased ...

    Research Review last updated 05/02/2016 - 9:32am.

  10. Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome

    ... multiple mechanisms. Panobinostat belongs to a class of chemotherapy drugs called "histone deacetylase (HDAC) inhibitors." HDAC ... causes them to die. Fludarabine and cytarabine are chemotherapy drugs that are commonly used to treat pediatric patients with ...

    Clinical Trial last updated 04/29/2016 - 10:11am.